Two optimized combination assays to examine apoptosis pathways in clinical samples

Cytometry Part A

Volumn 71, Issue 9, 2007, Pages 675-685

  Hollier, Mark ^a   Whistler, Toni ^a   Dawson, Carolyn ^b   Vernon, Suzanne D ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Apoptosis; Clinical samples; Combination; Flow cytometry; Limited cell number; Multiparameter; PBMC

Indexed keywords

CASPASE 12; DNA FRAGMENT; PHOSPHATIDYLSERINE;

APOPTOSIS; ARTICLE; BLOOD CELL; BLOOD SAMPLING; CELL COUNT; CELL POPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DEPOLARIZATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; MALE; PRIORITY JOURNAL;

APOPTOSIS; CAMPTOTHECIN; CASPASE 12; CASPASE 3; DNA FRAGMENTATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HL-60 CELLS; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MITOCHONDRIA; PHOSPHATIDYLSERINES;

EID: 34548324506     PISSN: 15524922     EISSN: 15524930     Source Type: Journal    
DOI: 10.1002/cyto.a.20422     Document Type: Article

References (58)

1. Gervais FG, Singaraja R, Xanthoudakis S, Gutekunst CA, Leavitt BR, Metzler M, Hackam AS, Tam J, Vaillancourt JP, Houtzager V, Rasper DM, Roy S, Hayden MR, Nicholson DW. Recruitment and activation of caspase-8 by the Huntingtin-interacting protein Hip-1 and a novel partner Hippi. Nat Cell Biol 2002;4:95-105.
2. Hickey MA, Chesselet MF. Apoptosis in Huntington's disease. Prog Neuropsychopharmacol Biol Psychiatry 2003;27:255-265.
3. Sanchez I, Xu CJ, Juo P, Kakizaka A, Blenis J, Yuan J. Caspase-8 is required for cell death induced by expanded polyglutamine repeats. Neuron 1999;22:623-633.
4. Fadeel B, Orrenius S, Zhivotovsky B. Apoptosis in human disease: A new skin for the old ceremony? Biochem Biophys Res Commun 1999;266:699-717.
5. Kitamura Y, Shimohama S, Kamoshima W, Ota T, Matsuoka Y, Nomura Y, Smith MA, Perry G, Whitehouse PJ, Taniguchi T. Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1 and CPP32, in Alzheimer's disease. Brain Res 1998;780:260-269.
6. Smale G, Nichols NR, Brady DR, Finch CE, Horton WE, Jr. Evidence for apoptotic cell death in Alzheimer's disease. Exp Neurol 1995;133:225-230.
7. Uetsuki T, Takemoto K, Nishimura I, Okamoto M, Niinobe M, Momoi T, Miura M, Yoshikawa K. Activation of neuronal caspase-3 by intracellular accumulation of wildtype Alzheimer amyloid precursor protein. J Neurosci 1999;19:6955-6964.
8. Hartmann A, Mouatt-Prigent A, Faucheux BA, Agid Y, Hirsch EC. FADD: A link between TNF family receptors and caspases in Parkinson's disease. Neurology 2002;58:308-310.
9. Tatton NA. Increased caspase 3 and Bax immunoreactivity accompany nuclear GAPDH translocation and neuronal apoptosis in Parkinson's disease. Exp Neurol 2000;166:29-43.
10. Tatton WG, Chalmers-Redman R, Brown D, Tatton N. Apoptosis in Parkinson's disease: Signals for neuronal degradation. Annals of Neurology 2003;53(S3):S61-S72.
11. Jones RA, Johnson VL, Buck NR, Dobrota M, Hinton RH, Chow SC, Kass GE. Fas-mediated apoptosis in mouse hepatocytes involves the processing and activation of caspases. Hepatology 1998;27:1632-1642.
12. Schuchmann M, Galle PR. Apoptosis in liver disease. Eur J Gastroenterol Hepatol 2001;13:785-790.
13. Spengler U, Zachoval R, Gallati H, Jung MC, Hoffmann R, Riethmuller G, Pape G. Serum levels and in situ expression of TNF-α and TNF-α binding proteins in inflammatory liver diseases. Cytokine 1996;8:864-872.
14. Narula J, Pandey P, Arbustini E, Haider N, Narula N, Kolodgie FD, Dal Bello B, Semigran MJ, Bielsa-Masdeu A, Dec GW, Israels S, Ballester M, Virmani R, Saxena S, Kharhanda S. Apoptosis in heart failure: Release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. Proc Natl Acad Sci USA 1999;96: 8144-149.
15. Neuss M, Crow MT, Chesley A, Lakatta EG. Apoptosis in cardiac disease - What is it - How does it occur. Cardiovasc Drugs Ther 2001;15:507-523.
16. Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, Quaini E, Di Loreto C, Beltrami CA, Krajewski S, Reed JC, Anversa P. Apoptosis in the failing human heart. N Engl J Med 1997;336:1131-1141.
17. Akdis CA, Blaser K, Akdis M. Apoptosis in tissue inflammation and allergic disease. Curr Opin Immunol 2004;16:717-723.
18. Akdis M, Trautmann A, Klunker S, Daigle I, Kucuksezer UC, Deglmann W, Disch R, Blaser K, Akdis CA. T helper (Th) 2 predominance in atopic diseases is due to preferential apoptosis of circulating memory/effector Th1 cells. FASEB J 2003;17:1026-1035.
19. Singh VK, Mehrotra S, Agarwal SS. The paradigm of Th1 and Th2 cytokines: Its relevance to autoimmunity and allergy. Immunol Res 1999;20:147-161.
20. Baize S, Leroy EM, Georges-Courbot MC, Capron M, Lansoud-Soukate J, Debre P, Fisher-Hoch SP, McCormick JB, Georges AJ. Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nat Med 1999;5:423-426.
21. Brown JM, Attardi FD. The role of apoptosis in cancer development and treatment response. Nat Rev Cancer 2005;5:231-237.
22. Vermeulen K, Van Bockstaele DR, Berneman ZN. Apoptosis: Mechanisms and relevance in cancer. Ann Hematol 2005;84:627-639.
23. Carrero JA, Calderon B, Unanue ER. Listeriolysin O from Listeria monocytogenes is a lymphocyte apoptogenic molecule. J Immunol 2004;172:4866-4874.
24. Douglas RS, Pletcher CH, Jr., Nowell PC, Moore JS. Novel approach for simultaneous evaluation of cell phenotype, apoptosis, and cell cycle using multiparameter flow cytometry. Cytometry 1998;32:57-65.
25. Hasper HJ, Weghorst RM, Richel DJ, Meerwaldt JH, Olthuis FM, Schenkeveld CE. A new four-color flow cytometric assay to detect apoptosis in lymphocyte subsets of cultured peripheral blood cells. Cytometry 2000;40:167-171.
26. Johnson EA, Svetlov SI, Wang KK, Hayes RL, Pineda JA. Cell-specific DNA fragmentation may be attenuated by a survivin-dependent mechanism after traumatic brain injury in rats. Exp Brain Res 2005;167:17-26.
27. Osella-Abate S, Zaccagna A, Savoia P, Quaglino P, Salomone B, Bernengo MG. Expression of apoptosis markers on peripheral blood lymphocytes from patients with cutaneous T-cell lymphoma during extracorporeal photochemotherapy. J Am Acad Dermatol 2001;44:40-47.
28. Poot M, Pierce RH. Detection of changes in mitochondrial function during apoptosis by simultaneous staining with multiple fluorescent dyes and correlated multiparameter flow cytometry. Cytometry 1999;35:311-317.
29. Rutella S, Rumi C, Pierelli L, Morosetti R, Sica S, Bonanno G, Scambia G, Leone G. Granulocyte colony-stimulating factor perturbs lymphocyte mitochondrial function and inhibits cell cycle progression. Exp Hematol 2000;28:612-625.
30. van Stijn A, Kok A, van der Pol MA, Feller N, Roemen GM, Westra AH, Ossenkoppele GJ, Schuurhuis GJ. Multiparameter flow cytometric quantification of apoptosis-related protein expression. Leukemia 2003;17:787-788.
31. Zhou C, Yamaguchi M, Kusaka G, Schonholz C, Nanda A, Zhang JH. Caspase inhibitors prevent endothelial apoptosis and cerebral vasospasm in dog model of experimental subarachnoid hemorrhage. J Cereb Blood Flow Metab 2004;24:419-431.
32. Danial NN, Korsmeyer SJ. Cell death: Critical control points. Cell 2004;116:205-219.
33. Hengartner MO. The biochemistry of apoptosis. Nature 2000;407:770-776.
34. Vaux DL, Strasser A. The molecular biology of apoptosis. Proc Natl Acad Sci USA 1996;93:2239-2244.
35. Ebert EC. Activation of human intraepithelial lymphocytes reduces CD3 expression. Clin Exp Immunol 2003;132:424-429.
36. Lauritsen JP, Christensen MD, Dietrich J, Kastrup J, Odum N, Geisler C. Two distinct pathways exist for down-regulation of the TCR. J Immunol 1998;161:260-267.
37. Valitutti S, Muller S, Cella M, Padovan E, Lanzavecchia A. Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature 1995;375:148-151.
38. Valitutti S, Muller S, Salio M, Lanzavecchia A. Degradation of T cell receptor (TCR)-CD3-zeta complexes after antigenic stimulation. J Exp Med 1997;185:1859-1864.
39. Dietrich J, Menne C, Lauritsen JP, von Essen M, Rasmussen AB, Odum N, Geisler C. Ligand-induced TCR down-regulation is not dependent on constitutive TCR cycling. J Immunol 2002;168:5434-5440.
40. Dumont C, Blanchard N, Di Bartolo V, Lezot N, Dufour E, Jauliac S, Hivroz C. TCR/CD3 down-modulation and zeta degradation are regulated by ZAP-70. J Immunol 2002;169:1705-1712.
41. Geisler C. TCR trafficking in resting and stimulated T cells. Crit Rev Immunol 2004;24:67-86.
42. Jager E, Salter R, Castelli C, Hohn H, Freitag K, Karbach J, Neukirch C, Necker A, Knuth A, Macurer MJ. Impact of antigen presentation on TCR modulation and cytokine release: Implications for detection and sorting of antigen-specific CD8+ T cells using HLA-A2 wild-type or HLA-A2 mutant tetrameric complexes. J Immunol 2002;168:2766-2772.
43. Liu H, Rhodes M, Wiest DL, Vignali DA. On the dynamics of TCR:CD3 complex cell surface expression and downmodulation. Immunity 2000;13:665-675.
44. San Jose E, Borroto A, Niedergang F, Alcover A, Alarcon B. Triggering the TCR complex causes the downregutation of nonengaged receptors by a signal transduction-dependent mechanism. Immunity 2000;12:161-170.
45. von Essen M, Menne C, Nielsen BL, Lauritsen JP, Dietrich J, Andersen PS, Karjalainen K, Odum N, Geisler C. The CD3 gamma leucine-based receptor-sorting motif is required for efficient ligand-mediated TCR down-regulation. J Immunol 2002;168:4519-4523.
46. Sun S, Han J, Ralph WM Jr, Chandrasekaran A, Liu K, Auborn KJ, Carter TH. Endoplasmic reticulum stress as a correlate of cytotoxicity in human tumor cells exposed to diindolylmethane in vitro. Cell Stress Chaperones 2004;9:76-87.
47. Nakagawa T, Zhu H, Morishima N, Li E, Xu J, Yankner BA, Yuan J. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β. Nature 2000;403:98-103.
48. Rao RV, Castro-Obregon S, Frankowski H, Schuler M, Stoka V, del Rio G, Bredesen DE, Ellerby HM. Coupling endoplasmic reticulum stress to the cell death program. An Apaf-1-independent intrinsic pathway. J Biol Chem 2002;277:21836-21842.
49. Mandic A, Hansson J, Linder S, Shoshan MC. Cisplatin induces endoplasmic reticulum stress and nucleus-independent apoptotic signaling. J Biol Chem 2003;278:9100-9106.
50. Tinhofer I, Anether G, Senfter M, Pfaller K, Bernhard D, Hara M, Greil R. Stressful death of T-ALL tumor cells after treatment with the anti-tumor agent Tetrocarcin-A. FASEB J 2002;16:1295-1297.
51. Sohn J, Khaoustov VI, Xie Q, Chung CC, Krishnan B, Yoffe B. The effect of ursodeoxycholic acid on the survivin in thapsigargin-induced apoptosis. Cancer Lett 2003;191:83-92.
52. Xie Q, Khaoustov VI, Chung CC, Sohn J, Krishnan B, Lewis DE, Yoffe B. Effect of tauroursodeoxycholic acid on endoplasmic reticulum stress-induced caspase-12 activation. Hepatology 2002;36:592-601.
53. Hetz C, Russelakis-Carneiro M, Maundrell K, Castilla J, Soto C. Caspase-12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein. EMBO J 2003;22:5435-5445.
54. Bitko V, Barik S. An endoplasmic reticulum-specific stress-activated caspase (caspase-12) is implicated in the apoptosis of A549 epithelial cells by respiratory syncytial virus. J Cell Biochem 2001;80:441-454.
55. Fischer H, Koenig U, Eckhart L, Tschachler E. Human caspase 12 has acquired deleterious mutations. Biochem Biophys Res Commun 2002;293:722-726.
56. Saleh M, Vaillancourt JP, Graham RK, Huyck M, Srinivasula SM, Alnemri ES, Steinberg MH, Nolan V, Baldwin CT, Hotchkiss RS, Buchman TG, Zehnbauer BA, Hayden MR, Farrer LA, Roy S, Nicholson DW. Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms. Nature 2004; 429:75-79.
57. Xue Y, Daly A, Yngvadottir B, Liu M, Coop G, Kim Y, Sabeti P, Chen Y, Stalker J, Huckle E, Burton J, Leonard S, Rogers J, Tyler-Smith C. Spread of an inactive form of caspase-12 in humans is due to recent positive selection. Am J Hum Genet 2006;78:659-670.
58. Pozarowski P, Huang X, Halicka DH, Lee B, Johnson G, Darzynkiewicz Z. Interactions of fluorochrome-labeled caspase inhibitors with apoptotic cells: A caution in data interpretation. Cytometry Part A 2003;55A:50-60.